Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-11-15
著者
-
HO A.
Department of Medicine V (Hematology/Oncology/Rheumatology), University of Heidelberg
-
Goldschmidt H.
Department Of Medicine V (hematology/oncology/rheumatology) University Of Heidelberg
-
MOEHLER T.
Department of Medicine V (Hematology/Oncology/Rheumatology), University of Heidelberg
-
Moehler T.
Department Of Medicine V (hematology/oncology/rheumatology) University Of Heidelberg
-
HILLENGASS J.
Department of Hematology, Oncology and Rheumatology, University Hospital of Heidelberg
-
WALDHERR R.
Gemeinschaftspraxis Pathologie
-
Hillengass J.
Department Of Hematology Oncology And Rheumatology University Hospital Of Heidelberg
関連論文
- Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myeloma
- Successful autologous peripheral blood stem cell transplantation in a Jehovah's Witness with multiple myeloma : review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood products
- Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis